Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced vs standard booster dose of mRNA COVID-19 vaccine after two doses of inactivated vaccine
TCTR20211120001Phase 4Completed
- Sponsor
- National Research Council of Thailand
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of mRNA COVID-19 vaccine in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Sep 2021; status: completed.
02
Drugs
mRNA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211120001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211120001.